Botox (Allergan, www.botoxcosmetic.com) was first approved in 1989 to treat two medical conditions involving muscle spasm (blepharospasm and strabismus), but since its approval to treat glabellar lines in 2002, it has become much more widely known as a cosmetic drug. That may soon change as more and more research points to the...
Articles
Branding and marketing are key components to building a successful medical aesthetics...
Situated in the scenic, southern California town of Laguna Niguel, overlooking the...
Sculpting bodies by removing unwanted fat from one location and transferring it to...
Products
The physician-dispensed glo•therapeutics Advanced Collection now includes...
The new ProWave LX hair removal handpiece from Cutera offers 10 Kilowatts of...
Canfield Imaging Systems has added the new IntelliPanel flash unit for its...
Young Pharmaceuticals’ HydraPeptide Gel is a highly concentrated hyaluronic...
Sheldon Pinnell, MD, J. Lamar Callaway Professor Emeritus of Dermatology and Chief Emeritus of the Division of Dermatology at Duke University, has received honorary membership in the Society for Investigative Dermatology at the International Investigative Dermatology meeting held in Edinburgh, Scotland. Dr. Pinnell has been researching new technologies to prevent skin cancer and photoaging for more than five decades. He is the founding scientist of Skinceuticals, a skincare line developed to combat photoaging, and recipient of numerous medical and scientific awards including; The Best Doctors in America, The International Who’s Who in Medicine, Who’s Who in Science and Engineering and Who’s Who in America.
Founded in 1937, the Society for Investigative Dermatology is a professional membership organization serving scientists and physicians working in academic settings, government and industry, and clinical practice. The International Investigative Dermatology meeting, held every five years, is one of the highest regarded assemblies within the dermatologic research community. As an honorary member, Dr. Pinnell will join a group of esteemed colleagues who have had a hand in advancing and promoting sciences relevant to skin...












